BYOMass Company
BYOMass is developing therapeutics to modulate the central control of metabolism associated with aging and age-related chronic illnesses.
Number Of Exists:
Venture - Series Unknown
Industry:
Biotechnology
Last Funding Type:
Venture - Series Unknown
Total Funding:
1500000
Investors Number:
1
Headquarters:
Sudbury, Massachusetts, United States
Technology:
Geroscience
Investor Type:
Company
Last Funding Date:
2019
Founded Date:
2017
Employee Number:
1-10